Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Steegmann

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Dermatology|January 10, 2018
Imatinib-induced pseudoporphyriaC Martinez-Mera, T M Capusan, M Herrero-Moyano, et al.
American Journal of Hematology|September 2, 1998
Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic responseJ L Steegmann, M J Requena, M L García-Buey, et al.
American Journal of Hematology|September 1, 1991
Unexpectedly high toxicity of MACOP-B in young patients with low grade lymphomaR Arranz, G Pérez, J L Steegmann, et al.
Sangre|April 1, 1997
[Allogeneic umbilical cord blood transplantation in overweight patients: evaluation of outcome, alloreactivity and morbidity. Preliminary results of a phase I study]R Romero, R Cabrera, C Regidor, et al.
American Journal of Hematology|July 1, 1995
Hypertriglyceridemia may be severe in CML patients treated with interferon-alphaM J Peñarrubia, J L Steegmann, E Lavilla, et al.
Journal of the National Cancer Institute|June 13, 1998
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project GroupJ Hasford, M Pfirrmann, R Hehlmann, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 25, 2012
Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish surveyJ L Steegmann, J M Sánchez Torres, R Colomer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
alpha Interferon in the management of essential thrombocythaemiaM Giralt, D Rubio, M T Cortés, et al.
Transfusion|April 1, 1997
The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, I Pinilla, M J Requena, et al.
American Journal of Hematology|February 28, 2003
High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, M J Requena, P Martín-Regueira, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Dermatology|January 10, 2018
Imatinib-induced pseudoporphyriaC Martinez-Mera, T M Capusan, M Herrero-Moyano, et al.
American Journal of Hematology|September 2, 1998
Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic responseJ L Steegmann, M J Requena, M L García-Buey, et al.
American Journal of Hematology|September 1, 1991
Unexpectedly high toxicity of MACOP-B in young patients with low grade lymphomaR Arranz, G Pérez, J L Steegmann, et al.
Sangre|April 1, 1997
[Allogeneic umbilical cord blood transplantation in overweight patients: evaluation of outcome, alloreactivity and morbidity. Preliminary results of a phase I study]R Romero, R Cabrera, C Regidor, et al.
American Journal of Hematology|July 1, 1995
Hypertriglyceridemia may be severe in CML patients treated with interferon-alphaM J Peñarrubia, J L Steegmann, E Lavilla, et al.
Journal of the National Cancer Institute|June 13, 1998
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project GroupJ Hasford, M Pfirrmann, R Hehlmann, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 25, 2012
Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish surveyJ L Steegmann, J M Sánchez Torres, R Colomer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
alpha Interferon in the management of essential thrombocythaemiaM Giralt, D Rubio, M T Cortés, et al.
Transfusion|April 1, 1997
The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, I Pinilla, M J Requena, et al.
American Journal of Hematology|February 28, 2003
High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, M J Requena, P Martín-Regueira, et al.
Pageof 7